HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Ho Selected Research

kappa Opioid Receptors (kappa Opioid Receptor)

8/2010Acute withdrawal from chronic escalating-dose binge cocaine administration alters kappa opioid receptor stimulation of [35S] guanosine 5'-O-[gamma-thio]triphosphate acid binding in the rat ventral tegmental area.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Ho Research Topics

Disease

5Neoplasms (Cancer)
01/2021 - 10/2000
4Cocaine-Related Disorders (Cocaine Addiction)
08/2010 - 07/2000
3Heroin Dependence (Heroin Abuse)
06/2010 - 05/2001
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2010 - 05/2007
2Diabetes Mellitus
01/2019 - 11/2016
2Colonic Neoplasms (Colon Cancer)
09/2013 - 08/2000
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2001 - 10/2001
1COVID-19
01/2021
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2017
1Ulcer
03/2017
1Prostatic Neoplasms (Prostate Cancer)
09/2015
1Thymoma (Thymic Carcinoma)
01/2015
1AIDS-Related Complex (ARC)
04/2013
1Ischemia
04/2013
1Anastomotic Leak
04/2013
1Asthma (Bronchial Asthma)
04/2012
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
11/2010
1Opioid-Related Disorders (Opiate Addiction)
12/2008
1Aneurysm (Aneurysms)
02/2008
1Skin Diseases (Skin Disease)
05/2007
1Refractory Anemia with Excess of Blasts (RAEM)
05/2007
1Lymphoma (Lymphomas)
09/2006
1Exfoliative Dermatitis (Erythroderma)
09/2006
1Cytopenia
02/2005
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
02/2005
1Neutropenia
02/2005
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2005
1Herpes Simplex
09/2001
1Retinoblastoma (Glioblastoma, Retinal)
07/2001

Drug/Important Bio-Agent (IBA)

5Methadone (Dolophine)FDA LinkGeneric
12/2008 - 11/2000
4Heroin (Diamorphine)IBA
04/2013 - 12/2000
3Messenger RNA (mRNA)IBA
01/2015 - 09/2001
2Insulin (Novolin)FDA Link
01/2019 - 02/2011
2Pro-Opiomelanocortin (Proopiomelanocortin)IBA
04/2013 - 09/2001
2Opioid Analgesics (Opioids)IBA
08/2010 - 12/2000
2DNA (Deoxyribonucleic Acid)IBA
04/2008 - 10/2001
2Azacitidine (5 Azacytidine)FDA Link
09/2007 - 05/2007
2Prostaglandins AIBA
10/2001 - 10/2001
1SodiumIBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1Imatinib Mesylate (Gleevec)FDA Link
11/2017
1Cytarabine (Cytosar-U)FDA LinkGeneric
11/2017
1InterferonsIBA
11/2017
1Blood Glucose (Blood Sugar)IBA
11/2016
1Mitogen-Activated Protein KinasesIBA
01/2015
1Ionotropic Glutamate ReceptorsIBA
01/2015
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2015
1Oxycodone (Oxycontin)FDA LinkGeneric
01/2015
1Methacholine Chloride (Methacholine)FDA Link
04/2012
1Exenatide (Byetta)FDA Link
02/2011
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2011
1Niacinamide (Nicotinamide)FDA LinkGeneric
02/2011
1Conditioned Culture MediaIBA
02/2011
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
11/2010
1kappa Opioid Receptors (kappa Opioid Receptor)IBA
08/2010
1Cocaine (Cocaine HCl)IBA
08/2010
1fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
06/2010
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
06/2010
1Alemtuzumab (Campath)FDA Link
04/2010
1CryptochromesIBA
04/2008
1Deoxyribodipyrimidine Photo-LyaseIBA
04/2008
1mu Opioid Receptors (mu Opioid Receptor)IBA
04/2008
1metabotropic glutamate receptor 8IBA
04/2008
1Member 2 Group A Nuclear Receptor Subfamily 4IBA
04/2008
1Transcription Factors (Transcription Factor)IBA
04/2008
1metabotropic glutamate receptor 6IBA
04/2008
1myocardinIBA
04/2008
1TitaniumIBA
02/2008
1TransferasesIBA
09/2007
1A-Form DNA (A-DNA)IBA
09/2007
1Interleukin-2 Receptor alpha SubunitIBA
09/2006
1Daclizumab (Zenapax)FDA Link
09/2006
1Inosine Triphosphate (ITP)IBA
02/2005
1Rituximab (Mabthera)FDA Link
02/2005
1EnzymesIBA
10/2001
1ImmunosorbentsIBA
10/2001
1Complement System Proteins (Complement)IBA
10/2001
1Thymidine KinaseIBA
09/2001
1Peptides (Polypeptides)IBA
09/2001
1Opioid Receptors (Opioid Receptor)IBA
09/2001
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
07/2001
1Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA
07/2001
1Cyclin-Dependent Kinases (cdk Proteins)IBA
07/2001
1Cyclin EIBA
07/2001
1Cyclin-Dependent Kinase Inhibitor p16IBA
07/2001
1E2F Transcription FactorsIBA
07/2001
1Cyclin DIBA
07/2001
1PolymersIBA
06/2001

Therapy/Procedure

6Therapeutics
01/2019 - 07/2000
3Self Administration (Administration, Self)
01/2015 - 07/2000
2Drug Therapy (Chemotherapy)
01/2021 - 10/2000
1Adjuvant Chemotherapy
01/2021
1Conservative Treatment
03/2017
1Colostomy
09/2013
1Esophagectomy
04/2013
1Neoadjuvant Therapy
04/2013
1Length of Stay
04/2013
1Surgical Instruments (Clip)
02/2008
1Radiotherapy
02/2008
1Stem Cell Transplantation
02/2005